| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/03/2013 | WO2012149546A3 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy |
| 01/03/2013 | WO2012148140A3 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof |
| 01/03/2013 | WO2012143524A3 Bispecific antibodies against her2 and cd3 |
| 01/03/2013 | WO2012141504A3 Brg-1-derived bromodomain, and use thereof |
| 01/03/2013 | WO2012138715A3 Small molecule inhibitors of xbp1 splicing |
| 01/03/2013 | WO2012138708A8 Mhc engagement and clip modulation for the treatment of disease |
| 01/03/2013 | WO2012135695A3 Modulation of cellular migration |
| 01/03/2013 | WO2012135149A3 Small molecule modulators of sirt1 activity activate p53 and suppress tumor growth |
| 01/03/2013 | WO2012134234A3 Use of hades as a negative modulator of akt |
| 01/03/2013 | WO2012129394A3 Methods and compositions for the treatment of cancer |
| 01/03/2013 | WO2012128521A3 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
| 01/03/2013 | WO2012122471A3 Compounds and methods of use in ablative radiotherapy |
| 01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
| 01/03/2013 | WO2012088491A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 01/03/2013 | WO2012062905A3 Chromene derivatives and their analoga as wnt pathway antagonists |
| 01/03/2013 | WO2009095796A3 Tapasin augmentation for enhanced immune response |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130006034 Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies |
| 01/03/2013 | US20130005837 Cancer biomarkers to predict recurrence and metastatic potential |
| 01/03/2013 | US20130005830 Sandalwood oil and its uses |
| 01/03/2013 | US20130005827 Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005826 Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005825 Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005813 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field |
| 01/03/2013 | US20130005799 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas |
| 01/03/2013 | US20130005793 Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005781 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 01/03/2013 | US20130005773 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 01/03/2013 | US20130005771 Oxadiazole compounds, their preparation and use |
| 01/03/2013 | US20130005769 Inhibitors of the interaction between mdm2 and p53 |
| 01/03/2013 | US20130005766 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/03/2013 | US20130005759 Small molecule modifiers of microrna mir-122 |
| 01/03/2013 | US20130005754 Solid forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005749 Novel formulation and treatment methods |
| 01/03/2013 | US20130005748 Compounds and compositions as protein kinase inhibitors |
| 01/03/2013 | US20130005747 Method for selecting a cancer therapy |
| 01/03/2013 | US20130005746 Inhibitors of brutons tyrosine kinase for the treatment of solid tumors |
| 01/03/2013 | US20130005738 Monocyclic Heteroaryl Compounds |
| 01/03/2013 | US20130005737 Compositions, methods and kits for treating leukemia |
| 01/03/2013 | US20130005733 Combination anti-cancer therapy |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005725 Chemical compounds |
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2013 | US20130005723 Triazine compounds as pi3 kinase and mtor inhibitors |
| 01/03/2013 | US20130005721 Indolizine inhibitors of 5-lipoxygenase |
| 01/03/2013 | US20130005720 Pharmaceutical composition for treating cancer and applications thereof |
| 01/03/2013 | US20130005713 Process for Preparing Diaminophenothiazinium Compounds |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005702 Pyrazole derivatives as protein kinase modulators |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005697 Progesterone Receptor Antagonists |
| 01/03/2013 | US20130005696 Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof |
| 01/03/2013 | US20130005694 Liquid compositions comprising vitamin d and uses thereof |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005678 Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate |
| 01/03/2013 | US20130005677 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
| 01/03/2013 | US20130005669 Novel synthetic glycolipid and use thereof |
| 01/03/2013 | US20130005664 Therapeutic agents comprising elastic peptides |
| 01/03/2013 | US20130005663 Smac peptidometics useful as iap inhibitors |
| 01/03/2013 | US20130005653 Polypeptides |
| 01/03/2013 | US20130005651 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130004977 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/03/2013 | US20130004605 Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells |
| 01/03/2013 | US20130004597 Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells |
| 01/03/2013 | US20130004596 Pharmaceutical composition for treating diabetes containing quamoclit angulata extract |
| 01/03/2013 | US20130004551 Biotinylated hexadecasaccharides, preparation and use thereof |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004523 Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles |
| 01/03/2013 | US20130004521 Targeting cancer stem cells |
| 01/03/2013 | US20130004520 Methods and materials related to hair pigmentation and cancer |
| 01/03/2013 | US20130004519 Smoci, tenascin-c and brain cancers |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004498 Dosing for treatment with anti-egfl7 antibodies |
| 01/03/2013 | US20130004492 Fgfr extracellular domain acidic region muteins |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004489 Activin-actriia antagonists and uses for treating multiple myeloma |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004484 Anti-c-met antibody formulations |
| 01/03/2013 | US20130004483 Medical methods and agents for use therein |
| 01/03/2013 | US20130004482 Methods of Treating Breast Cancer with Anthracycline Therapy |
| 01/03/2013 | US20130004481 Anticancer therapy |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004459 Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma |
| 01/03/2013 | US20130004456 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/03/2013 | US20130004436 Compositions and Methods of Treating and Preventing Lung Cancer and Lymphangioleiomyomatosis |
| 01/03/2013 | US20130004432 Monoclonal antibodies that bind b7h6 and uses thereof |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004429 Use of a neurofilament peptide for the treatment of glioma |
| 01/03/2013 | US20130004427 Targeted dendrimer-drug conjugates |
| 01/03/2013 | US20130004424 Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors |
| 01/03/2013 | US20130004423 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/03/2013 | US20130004420 Hypervalent radioactive astatine or iodine compounds, and preparation methods thereof |
| 01/03/2013 | US20130004417 Gold Coated Lanthanide Nanoparticles |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |